Schedule 13G-A/1, Comvita

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DvDwzSWhFF5nPQhxy5Z0Wtj7Jbp1kU/6wzuxvTna2TmXnF/wJpijZp2u/Jb7Rmoy 8v8XoLCQZtcbK5YFVtwYUg== 0001088020-06-000056.txt : 20060821 0001088020-06-000056.hdr.sgml : 20060821 20060821110358 ACCESSION NUMBER: 0001088020-06-000056 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060821 DATE AS OF CHANGE: 20060821 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-52013 FILM NUMBER: 061045234 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Comvita New Zealand LTD CENTRAL INDEX KEY: 0001365190 IRS NUMBER: 000000000 STATE OF INCORPORATION: Q2 FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: WILSON ROAD SOUTH STREET 2: PAENGAROA, PRIVATE BAG 1 CITY: TE PUKE STATE: Q2 ZIP: 00000 BUSINESS PHONE: 64 75 33 17 33 MAIL ADDRESS: STREET 1: WILSON ROAD SOUTH STREET 2: PAENGAROA, PRIVATE BAG 1 CITY: TE PUKE STATE: Q2 ZIP: 00000 SC 13G/A 1 sc13g-a1_comvita.htm AMENDMENT NO. 1 Schedule 13G-A/1, Comvita


	OMB APPROVAL
	OMB Number:	3235-0145
UNITED STATES	Expires:	February 28, 2009
SECURITIES AND EXCHANGE COMMISSION	Estimated average burden
WASHINGTON, D.C. 20549	hours per response. . . . 10.4

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Derma Sciences, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

249827106

(CUSIP Number)

August 3, 2006

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


	o Rule 13d-1(b)

	x Rule 13d-1(c)

	o Rule 13d-1(d)

___________________________

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the propose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of the section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

CUSIP No. 249827106

13G

Page 1 of 1 Pages


1.	NAMES OF REPORTING PERSONS
			Comvita New Zealand Limited
	I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
			None (foreign entity)
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
	(a) o (b) o
3.	SEC USE ONLY
4.	CITIZENSHIP OR PLACE OF ORGANIZATION
			New Zealand
NUMBER OF SHARES		5.	SOLE VOTING POWER 4,083,330
BENEFICIALLY OWNED BY		6.	SHARED VOTING POWER
EACH REPORTING		7.	SOLE DISPOSITIVE POWER 4,083,330
PERSON WITH		8.	SHARED DOSPOSITIVE POWER
9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
			4,083,330
10.	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
			o
11.	PERCENT OF CLASS REPRESENTED BY AMOUNT OF ROW 9
			16.1%
12.	TYPE OF REPORTING PERSON
			CO

Item 1.

1(a).

Name of Issuer:

Derma Sciences, Inc.

1(b).

Address of Issuer’s Principal Executive Offices:

214 Carnegie Center, Suite 100, Princeton, New Jersey 08540

Item 2.

2(a).

Name of Person Filing:

Comvita New Zealand Limited

2(b).

Address of Principal Business Office or, if None, Residence:

Wilson Road South, Paengaroa, Private Bag 1, Te Puke, New Zealand

2(c).

Citizenship:

Not Applicable

2(d).

Title of Class of Securities:

This statement covers a total of 4,083,330 fully diluted shares of Common Stock, $.01 par value per share (the “Common Stock”), of the Issuer. The Reporting Person as of the date hereof holds an aggregate of: (i) 3,666,664 shares of Common Stock, and (ii) warrants for the purchase of Common Stock (the “Warrants”) which as of the date hereof may be exercised to purchase all or a portion of 416,666 shares of Common Stock at a per share price of $1.00. The Common Stock and Warrants are referred to herein, collectively, as the “Securities”.

2(e).

CUSIP Number:

249827106

Item 3.

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:


3(a).	o	Broker or dealer registered under Section 15 of the Exchange Act.
3(b).	o	Bank as defined in Section 3(a)(6) of the Exchange Act.
3(c).	o	Insurance company as defined in Section 3(3)(19) of the Exchange Act.
3(d).	o	Investment company registered under Section 8 of the Investment Company Act.
3(e).	o	An investment adviser in accordance with Rule 13d-1(b) (1)(ii)(E);
3(f).	o	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(G);
3(g).	o	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(II)(G);
3(h).	o	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
3(i).	o	A church plan that is excluded from the definition of an investment company under Section 3(c ) (14) of the Investment Company Act;
3(j).	o	Group in accordance with Rule 13e-1(b)(1)(ii)(J).

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1:

4(a).

Amount beneficially owned:

4,083,330 shares

4(b).

Percent of class:

16.1%

4(c).

Number of shares as to which such person has:


(i)	Sole power to vote or to direct the vote:	4,083,330
(ii)	Shared power to vote or to direct the vote:	None
(iii)	Sole power to dispose or to direct the disposition of:	4,083,330
(iv)	Shared power to dispose or to direct the disposition of:	None

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications.

By signing below I certify that, to the best of my knowledge and belief, the Securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the Securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signatures

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


	COMVITA NEW ZEALAND LIMITED
	By: Rob Tait, Project Manager
	By:	/s/ Raymond C. Hedger, Jr.
		Raymond C. Hedger, Jr. Attorney-in-fact

August 21, 2006

-----END PRIVACY-ENHANCED MESSAGE-----